Sinuo Medical (688108.SH): the new drug-eluting stent system has received conditional approval from the US FDA.

The Zhitong Finance and Economics APP news, CIMC Medical (688108.SH) announced that the company submitted the registration application materials for the company's new drug eluting stent system to the US Food and Drug Administration (referred to as "FDA") in December 2021. The company recently received notification from the US FDA that the company's new drug eluting stent system PMA application has been conditionally approved by the FDA, and the US FDA will issue the formal approval for the company after the company completes the required targeted improvements.